Loading…
Lobbying Spend
—
Filings
75
Firms Hired
1
Active Period
2009–2026
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Consolidated Appropriations Act, 2023
2022 · fourth_quarter · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R.2617 - Consolidated Appropriations Act, 2023
Client expense: — · Firm income: $60,000
Matched citations: H.R.2617
Consolidated Appropriations Act, 2023
2022 · fourth_quarter · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R. 5376, the Inflation Reduction Act H.R. 6000, the CURES 2.0 Act S. 4348, FDA Safety and Landmark Advancements Act H.R. 7667, Food and Drug Amendments of 2022 Improving Needed Safeguards for Users of Lifesaving Insulin Now (INSULIN) Act H.R.2617, Consolidated Appropriations Act, 2023 importation, supply chain integrity, 304b, orphan drugs, newborn screening, expanded access, priority review, transparency, drug shortages, drug pricing, insulin, international reference pricing, user fee reauthorization
Client expense: — · Firm income: $60,000
Matched citations: H.R.2617
Inflation Reduction Act of 2022
2022 · fourth_quarter · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R. 5376, the Inflation Reduction Act H.R. 6000, the CURES 2.0 Act S. 4348, FDA Safety and Landmark Advancements Act H.R. 7667, Food and Drug Amendments of 2022 Improving Needed Safeguards for Users of Lifesaving Insulin Now (INSULIN) Act H.R.2617, Consolidated Appropriations Act, 2023 importation, supply chain integrity, 304b, orphan drugs, newborn screening, expanded access, priority review, transparency, drug shortages, drug pricing, insulin, international reference pricing, user fee reauthorization
Client expense: — · Firm income: $60,000
Matched citations: H.R. 5376
Inflation Reduction Act of 2022
2022 · fourth_quarter · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R. 5376, the Inflation Reduction Act Medicare Reimbursement, Medicaid Rebate, Medicaid Coverage and Reimbursement, quality indicators, coding, oncology, CMMI, Part B, ASP, insulin access, vaccines, flu, prescription drug access and affordability, transparency, international reference pricing, Medicaid Value Based Payment rule
Client expense: — · Firm income: $60,000
Matched citations: H.R. 5376
H.R. 5376, the Inflation Reduction Act H.R. 6000, the CURES 2.0 Act S. 4348, FDA Safety and Landmark Advancements Act H.R. 7667, Food and Drug Amendments of 2022 Improving Needed Safeguards for Users of Lifesaving Insulin Now (INSULIN) Act H.R.2617, Consolidated Appropriations Act, 2023 importation, supply chain integrity, 304b, orphan drugs, newborn screening, expanded access, priority review, transparency, drug shortages, drug pricing, insulin, international reference pricing, user fee reauthorization
Client expense: — · Firm income: $60,000
Matched citations: H.R. 6000
Food and Drug Amendments of 2022
2022 · fourth_quarter · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R. 5376, the Inflation Reduction Act H.R. 6000, the CURES 2.0 Act S. 4348, FDA Safety and Landmark Advancements Act H.R. 7667, Food and Drug Amendments of 2022 Improving Needed Safeguards for Users of Lifesaving Insulin Now (INSULIN) Act H.R.2617, Consolidated Appropriations Act, 2023 importation, supply chain integrity, 304b, orphan drugs, newborn screening, expanded access, priority review, transparency, drug shortages, drug pricing, insulin, international reference pricing, user fee reauthorization
Client expense: — · Firm income: $60,000
Matched citations: H.R. 7667
H.R. 5376, the Inflation Reduction Act H.R. 6000, the CURES 2.0 Act S. 4348, FDA Safety and Landmark Advancements Act H.R. 7667, Food and Drug Amendments of 2022 Improving Needed Safeguards for Users of Lifesaving Insulin Now (INSULIN) Act H.R.2617, Consolidated Appropriations Act, 2023 importation, supply chain integrity, 304b, orphan drugs, newborn screening, expanded access, priority review, transparency, drug shortages, drug pricing, insulin, international reference pricing, user fee reauthorization
Client expense: — · Firm income: $60,000
Matched citations: S. 4348
Consolidated Appropriations Act, 2023
2022 · fourth_quarter · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R.2617 - Consolidated Appropriations Act, 2023
Client expense: — · Firm income: $60,000
Matched citations: H.R.2617
Consolidated Appropriations Act, 2023
2022 · fourth_quarter · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R. 5376, the Inflation Reduction Act H.R. 6000, the CURES 2.0 Act S. 4348, FDA Safety and Landmark Advancements Act H.R. 7667, Food and Drug Amendments of 2022 Improving Needed Safeguards for Users of Lifesaving Insulin Now (INSULIN) Act H.R.2617, Consolidated Appropriations Act, 2023 importation, supply chain integrity, 304b, orphan drugs, newborn screening, expanded access, priority review, transparency, drug shortages, drug pricing, insulin, international reference pricing, user fee reauthorization
Client expense: — · Firm income: $60,000
Matched citations: H.R.2617
Inflation Reduction Act of 2022
2022 · fourth_quarter · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R. 5376, the Inflation Reduction Act H.R. 6000, the CURES 2.0 Act S. 4348, FDA Safety and Landmark Advancements Act H.R. 7667, Food and Drug Amendments of 2022 Improving Needed Safeguards for Users of Lifesaving Insulin Now (INSULIN) Act H.R.2617, Consolidated Appropriations Act, 2023 importation, supply chain integrity, 304b, orphan drugs, newborn screening, expanded access, priority review, transparency, drug shortages, drug pricing, insulin, international reference pricing, user fee reauthorization
Client expense: — · Firm income: $60,000
Matched citations: H.R. 5376
Inflation Reduction Act of 2022
2022 · fourth_quarter · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R. 5376, the Inflation Reduction Act Medicare Reimbursement, Medicaid Rebate, Medicaid Coverage and Reimbursement, quality indicators, coding, oncology, CMMI, Part B, ASP, insulin access, vaccines, flu, prescription drug access and affordability, transparency, international reference pricing, Medicaid Value Based Payment rule
Client expense: — · Firm income: $60,000
Matched citations: H.R. 5376
H.R. 5376, the Inflation Reduction Act H.R. 6000, the CURES 2.0 Act S. 4348, FDA Safety and Landmark Advancements Act H.R. 7667, Food and Drug Amendments of 2022 Improving Needed Safeguards for Users of Lifesaving Insulin Now (INSULIN) Act H.R.2617, Consolidated Appropriations Act, 2023 importation, supply chain integrity, 304b, orphan drugs, newborn screening, expanded access, priority review, transparency, drug shortages, drug pricing, insulin, international reference pricing, user fee reauthorization
Client expense: — · Firm income: $60,000
Matched citations: H.R. 6000
Food and Drug Amendments of 2022
2022 · fourth_quarter · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R. 5376, the Inflation Reduction Act H.R. 6000, the CURES 2.0 Act S. 4348, FDA Safety and Landmark Advancements Act H.R. 7667, Food and Drug Amendments of 2022 Improving Needed Safeguards for Users of Lifesaving Insulin Now (INSULIN) Act H.R.2617, Consolidated Appropriations Act, 2023 importation, supply chain integrity, 304b, orphan drugs, newborn screening, expanded access, priority review, transparency, drug shortages, drug pricing, insulin, international reference pricing, user fee reauthorization
Client expense: — · Firm income: $60,000
Matched citations: H.R. 7667
H.R. 5376, the Inflation Reduction Act H.R. 6000, the CURES 2.0 Act S. 4348, FDA Safety and Landmark Advancements Act H.R. 7667, Food and Drug Amendments of 2022 Improving Needed Safeguards for Users of Lifesaving Insulin Now (INSULIN) Act H.R.2617, Consolidated Appropriations Act, 2023 importation, supply chain integrity, 304b, orphan drugs, newborn screening, expanded access, priority review, transparency, drug shortages, drug pricing, insulin, international reference pricing, user fee reauthorization
Client expense: — · Firm income: $60,000
Matched citations: S. 4348
American Rescue Plan Act of 2021
2022 · third_quarter · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R. 1319, American Rescue Plan of 2021 implementation S. 1260, U.S. Innovation and Competition Act of 2021 H.R. 5376, the Inflation Reduction Act H.R. 6000, the CURES 2.0 Act S. 4348, FDA Safety and Landmark Advancements Act H.R. 7667, Food and Drug Amendments of 2022 Improving Needed Safeguards for Users of Lifesaving Insulin Now (INSULIN) Act importation, supply chain integrity, 304b, orphan drugs, newborn screening, expanded access, priority review, transparency, drug shortages, drug pricing, insulin, international reference pricing, user fee reauthorization
Client expense: — · Firm income: $60,000
Matched citations: H.R. 1319
Inflation Reduction Act of 2022
2022 · third_quarter · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R. 1319, American Rescue Plan of 2021 implementation S. 1260, U.S. Innovation and Competition Act of 2021 H.R. 5376, the Inflation Reduction Act H.R. 6000, the CURES 2.0 Act S. 4348, FDA Safety and Landmark Advancements Act H.R. 7667, Food and Drug Amendments of 2022 Improving Needed Safeguards for Users of Lifesaving Insulin Now (INSULIN) Act importation, supply chain integrity, 304b, orphan drugs, newborn screening, expanded access, priority review, transparency, drug shortages, drug pricing, insulin, international reference pricing, user fee reauthorization
Client expense: — · Firm income: $60,000
Matched citations: H.R. 5376
Inflation Reduction Act of 2022
2022 · third_quarter · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R. 5376, the Inflation Reduction Act Medicare Reimbursement, Medicaid Rebate, Medicaid Coverage and Reimbursement, quality indicators, coding, oncology, CMMI, Part B, ASP, insulin access, vaccines, flu, prescription drug access and affordability, transparency, international reference pricing, Medicaid Value Based Payment rule
Client expense: — · Firm income: $60,000
Matched citations: H.R. 5376
H.R. 1319, American Rescue Plan of 2021 implementation S. 1260, U.S. Innovation and Competition Act of 2021 H.R. 5376, the Inflation Reduction Act H.R. 6000, the CURES 2.0 Act S. 4348, FDA Safety and Landmark Advancements Act H.R. 7667, Food and Drug Amendments of 2022 Improving Needed Safeguards for Users of Lifesaving Insulin Now (INSULIN) Act importation, supply chain integrity, 304b, orphan drugs, newborn screening, expanded access, priority review, transparency, drug shortages, drug pricing, insulin, international reference pricing, user fee reauthorization
Client expense: — · Firm income: $60,000
Matched citations: H.R. 6000
Continuing Appropriations and Ukraine Supplemental Appropriations Act, 2023
2022 · third_quarter · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R. 6833, Continuing Appropriations and Ukraine Supplemental Appropriations Act of 2023
Client expense: — · Firm income: $60,000
Matched citations: H.R. 6833
Food and Drug Amendments of 2022
2022 · third_quarter · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R. 1319, American Rescue Plan of 2021 implementation S. 1260, U.S. Innovation and Competition Act of 2021 H.R. 5376, the Inflation Reduction Act H.R. 6000, the CURES 2.0 Act S. 4348, FDA Safety and Landmark Advancements Act H.R. 7667, Food and Drug Amendments of 2022 Improving Needed Safeguards for Users of Lifesaving Insulin Now (INSULIN) Act importation, supply chain integrity, 304b, orphan drugs, newborn screening, expanded access, priority review, transparency, drug shortages, drug pricing, insulin, international reference pricing, user fee reauthorization
Client expense: — · Firm income: $60,000
Matched citations: H.R. 7667
United States Innovation and Competition Act of 2021
2022 · third_quarter · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R. 1319, American Rescue Plan of 2021 implementation S. 1260, U.S. Innovation and Competition Act of 2021 H.R. 5376, the Inflation Reduction Act H.R. 6000, the CURES 2.0 Act S. 4348, FDA Safety and Landmark Advancements Act H.R. 7667, Food and Drug Amendments of 2022 Improving Needed Safeguards for Users of Lifesaving Insulin Now (INSULIN) Act importation, supply chain integrity, 304b, orphan drugs, newborn screening, expanded access, priority review, transparency, drug shortages, drug pricing, insulin, international reference pricing, user fee reauthorization
Client expense: — · Firm income: $60,000
Matched citations: S. 1260
H.R. 1319, American Rescue Plan of 2021 implementation S. 1260, U.S. Innovation and Competition Act of 2021 H.R. 5376, the Inflation Reduction Act H.R. 6000, the CURES 2.0 Act S. 4348, FDA Safety and Landmark Advancements Act H.R. 7667, Food and Drug Amendments of 2022 Improving Needed Safeguards for Users of Lifesaving Insulin Now (INSULIN) Act importation, supply chain integrity, 304b, orphan drugs, newborn screening, expanded access, priority review, transparency, drug shortages, drug pricing, insulin, international reference pricing, user fee reauthorization
Client expense: — · Firm income: $60,000
Matched citations: S. 4348
American Rescue Plan Act of 2021
2022 · second_quarter · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R. 1319, American Rescue Plan of 2021 implementation S. 1260, U.S. Innovation and Competition Act of 2021 H.R. 5376, the Build Back Better Act H.R. 6000, the CURES 2.0 Act S. 4348, FDA Safety and Landmark Advancements Act H.R. 7667, Food and Drug Amendments of 2022 Improving Needed Safeguards for Users of Lifesaving Insulin Now (INSULIN) Act importation, supply chain integrity, 304b, orphan drugs, newborn screening, expanded access, priority review, transparency, drug shortages, drug pricing, insulin, international reference pricing, user fee reauthorization
Client expense: — · Firm income: $60,000
Matched citations: H.R. 1319
Consolidated Appropriations Act, 2022
2022 · second_quarter · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R. 2471, Consolidated Appropriations Act 2022 deficit reduction, appropriations, biodefense, reconciliation
Client expense: — · Firm income: $60,000
Matched citations: H.R. 2471
Inflation Reduction Act of 2022
2022 · second_quarter · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R. 1319, American Rescue Plan of 2021 implementation S. 1260, U.S. Innovation and Competition Act of 2021 H.R. 5376, the Build Back Better Act H.R. 6000, the CURES 2.0 Act S. 4348, FDA Safety and Landmark Advancements Act H.R. 7667, Food and Drug Amendments of 2022 Improving Needed Safeguards for Users of Lifesaving Insulin Now (INSULIN) Act importation, supply chain integrity, 304b, orphan drugs, newborn screening, expanded access, priority review, transparency, drug shortages, drug pricing, insulin, international reference pricing, user fee reauthorization
Client expense: — · Firm income: $60,000
Matched citations: H.R. 5376
Source: Senate LDA